Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Your BMI is 30 or higher, and you have diastolic heart failure, high blood pressure, chronic kidney disease, prediabetes, a previous heart attack or stroke or peripheral artery disease
The new offering combines personalized microdoses of GLP-1 medication, regular at-home biomarker testing, and Nooms digital healthy habits platform to empower people with data, insights, personalized action plans, and the motivational support to take control of their long-term wellbeing
Yet, early clinical findings for opioid use disorder are promising, with a small randomized, double-blind, placebo-controlled residential study reporting an 40% reduction in opioid craving with liraglutide relative to placebo (Freet et al., 2025)
Its mechanism of action is primarily centered around its ability to promote fat breakdown and metabolism
